Stock listing
NASDAQ:BNTX BioNTech SE Stock
Home listing (NASDAQ) of BioNTech SE
Follow BioNTech SE into a list and get an email when it puts out news.
Share price · NASDAQ:BNTX
$89.67 USD -1.62 (-1.8%)
Close on Oct 22, 2026
- Day range
- $89.03 – $92.73 USDOct 22, 2026
- Volume
- 1.16M sharesOct 22, 2026
- Market cap
- $22.53B USDAt the close on Oct 22, 2026 · price × 251.2M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BNTX · Home | $89.67 USD | -1.62 (-1.8%) | 1,164,434 | $90.75 | $92.73 | $89.03 | $91.29 | Close on Oct 22, 2026 |
| B3:B1NT34 | 29.00 BRL | +0.38 (+1.3%) | 188 | 28.71 | 29.00 | 28.68 | 28.62 | Close on Oct 22, 2026 |
| Xetra:22UA | €81.55 EUR | -0.05 (-0.1%) | 18,970 | €81.40 | €82.70 | €80.10 | €81.60 | Close on Oct 22, 2026 |
Daily closes
Last 3 months, Jul 22, 2026 – Oct 22, 2026 · NASDAQ:BNTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $89.67 | -1.62 | -1.8% | $90.75 | $92.73 | $89.03 | 1,164,434 | |
| $91.29 | +0.12 | +0.1% | $91.25 | $92.35 | $91.02 | 1,113,196 | |
| $91.17 | +1.96 | +2.2% | $89.50 | $91.43 | $88.68 | 1,802,968 | |
| $89.21 | +1.50 | +1.7% | $87.94 | $89.80 | $87.73 | 1,327,103 | |
| $87.71 | -2.49 | -2.8% | $90.14 | $90.14 | $87.36 | 1,104,149 | |
| $90.20 | +1.54 | +1.7% | $88.92 | $90.72 | $88.46 | 1,056,803 | |
| $88.66 | -0.35 | -0.4% | $89.01 | $90.50 | $88.57 | 1,130,400 | |
| $89.01 | -6.83 | -7.1% | $92.36 | $93.08 | $88.85 | 1,951,100 | |
| $95.84 | -1.12 | -1.2% | $97.61 | $98.60 | $95.75 | 1,277,000 | |
| $96.96 | +4.90 | +5.3% | $92.45 | $97.40 | $92.30 | 1,320,400 | |
| $92.06 | -3.19 | -3.3% | $93.81 | $94.45 | $91.64 | 1,205,700 | |
| $95.25 | -0.48 | -0.5% | $95.17 | $97.46 | $93.92 | 828,000 | |
| $95.73 | -1.91 | -2.0% | $99.49 | $100.02 | $95.31 | 899,400 | |
| $97.64 | +0.74 | +0.8% | $96.74 | $98.79 | $95.20 | 1,436,200 | |
| $96.90 | +0.05 | +0.1% | $97.35 | $98.00 | $96.22 | 696,000 | |
| $96.85 | -1.45 | -1.5% | $97.59 | $99.49 | $96.60 | 820,000 | |
| $98.30 | -0.27 | -0.3% | $98.28 | $99.14 | $96.90 | 845,100 | |
| $98.57 | -0.51 | -0.5% | $98.43 | $99.79 | $97.60 | 736,900 | |
| $99.08 | +0.56 | +0.6% | $97.00 | $100.21 | $96.64 | 781,200 | |
| $98.52 | -0.74 | -0.7% | $99.51 | $100.02 | $97.73 | 580,000 | |
| $99.26 | +0.80 | +0.8% | $97.62 | $99.93 | $97.05 | 803,400 | |
| $98.46 | -2.41 | -2.4% | $100.61 | $101.31 | $98.31 | 1,087,400 | |
| $100.87 | +2.87 | +2.9% | $98.00 | $102.23 | $97.46 | 1,050,500 | |
| $98.00 | +1.94 | +2.0% | $97.25 | $98.98 | $96.61 | 800,800 | |
| $96.06 | -2.60 | -2.6% | $98.81 | $99.25 | $95.71 | 1,195,300 | |
| $98.66 | +2.83 | +3.0% | $97.50 | $99.58 | $97.13 | 708,000 | |
| $95.83 | -0.86 | -0.9% | $97.24 | $97.32 | $95.32 | 407,500 | |
| $96.69 | -2.17 | -2.2% | $97.04 | $97.66 | $95.80 | 590,400 | |
| $98.86 | +2.13 | +2.2% | $102.01 | $103.00 | $97.95 | 1,213,100 | |
| $96.73 | +0.33 | +0.3% | $96.77 | $97.90 | $96.00 | 1,176,300 | |
| $96.40 | -1.73 | -1.8% | $97.50 | $97.50 | $95.85 | 773,700 | |
| $98.13 | -0.53 | -0.5% | $98.50 | $98.64 | $96.87 | 706,900 | |
| $98.66 | -5.10 | -4.9% | $100.24 | $101.33 | $98.18 | 1,127,400 | |
| $103.76 | +0.88 | +0.9% | $102.78 | $104.82 | $102.33 | 626,000 | |
| $102.88 | -0.93 | -0.9% | $104.55 | $105.15 | $102.25 | 1,180,600 | |
| $103.81 | +1.865 | +1.8% | $103.24 | $105.46 | $102.51 | 753,600 | |
| $101.95 | +0.335 | +0.3% | $100.98 | $102.14 | $100.30 | 1,040,100 | |
| $101.61 | -0.465 | -0.5% | $102.01 | $103.00 | $100.84 | 1,089,800 | |
| $102.08 | -9.325 | -8.4% | $102.34 | $105.23 | $98.80 | 3,070,700 | |
| $111.40 | -1.16 | -1.0% | $111.69 | $112.81 | $110.25 | 1,551,100 | |
| $112.56 | -1.49 | -1.3% | $112.91 | $113.97 | $111.22 | 1,255,000 | |
| $114.05 | +1.23 | +1.1% | $113.88 | $116.87 | $113.41 | 1,359,000 | |
| $112.82 | -3.75 | -3.2% | $114.03 | $114.20 | $110.52 | 1,850,600 | |
| $116.57 | +5.68 | +5.1% | $110.92 | $120.33 | $110.89 | 2,960,400 | |
| $110.89 | -2.23 | -2.0% | $109.06 | $112.39 | $106.38 | 3,534,300 | |
| $113.12 | +20.37 | +22.0% | $109.29 | $116.00 | $107.18 | 8,780,300 | |
| $92.75 | +1.15 | +1.3% | $91.49 | $93.03 | $91.01 | 921,600 | |
| $91.60 | -1.49 | -1.6% | $93.22 | $93.76 | $91.23 | 443,500 | |
| $93.09 | +0.97 | +1.1% | $91.73 | $93.24 | $90.52 | 650,500 | |
| $92.12 | -0.62 | -0.7% | $92.89 | $93.20 | $91.69 | 988,500 | |
| $92.74 | -0.06 | -0.1% | $92.26 | $93.80 | $92.00 | 476,500 | |
| $92.80 | 0.00 | 0.0% | $92.84 | $93.23 | $92.04 | 705,979 | |
| $92.80 | -0.87 | -0.9% | $94.10 | $94.25 | $92.60 | 731,127 | |
| $93.67 | +2.48 | +2.7% | $91.90 | $94.27 | $91.57 | 1,427,900 | |
| $91.19 | -0.99 | -1.1% | $92.50 | $92.65 | $89.70 | 1,349,900 | |
| $92.18 | +0.83 | +0.9% | $91.42 | $92.96 | $90.40 | 1,700,700 | |
| $91.35 | -0.90 | -1.0% | $88.98 | $93.75 | $88.20 | 2,000,000 | |
| $92.25 | +1.67 | +1.8% | $91.01 | $94.41 | $89.50 | 1,119,500 | |
| $90.58 | -2.27 | -2.4% | $93.04 | $93.04 | $90.45 | 710,900 | |
| $92.85 | -0.10 | -0.1% | $92.12 | $93.15 | $92.00 | 1,381,300 | |
| $92.95 | +0.50 | +0.5% | $92.30 | $94.38 | $91.93 | 740,100 | |
| $92.45 | +1.36 | +1.5% | $91.78 | $92.71 | $90.84 | 679,300 | |
| $91.09 | +1.76 | +2.0% | $89.48 | $92.11 | $88.50 | 686,700 | |
| $89.33 | -2.73 | -3.0% | $92.00 | $92.19 | $88.92 | 886,000 | |
| $92.06 | +0.23 | +0.3% | $90.79 | $92.40 | $90.49 | 539,200 | |
| $91.83 | -0.50 | -0.5% | $92.33 | $93.15 | $91.61 | 508,300 |
- Ticker
- NASDAQ:BNTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 22, 2026
BioNTech Advances Phase 3 Clinical Trial of Pumitamig in Combination with Gilead’s TROP2-Directed ADC Sacituzumab Govitecan in Triple-Negative Breast Cancer
Latest deck · Aug 4, 2026
Q2 2026 Earnings Presentation
Earnings · 30 slides
Calls
Upcoming
BioNTech (NASDAQ:BNTX) Q3 2026 Earnings Call
Tue, Nov 03, 2026 · 8:00 AM ET
Register
Latest news
BioNTech Advances Phase 3 Clinical Trial of Pumitamig in Combination with Gilead’s TROP2-Directed ADC Sacituzumab Govitecan in Triple-Negative Breast Cancer
Oct 22, 2026
Closed $89.67 (-1.8%) on Oct 22, 2026
BioNTech and Australia’s State of Victoria Celebrate Milestone in Strategic Partnership to Strengthen mRNA Ecosystem
Oct 21, 2026
Closed $91.29 (+0.1%) on Oct 21, 2026
BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026
Oct 20, 2026
Closed $91.17 (+2.2%) on Oct 20, 2026
BioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026
Oct 19, 2026
Closed $89.21 (+1.7%) on Oct 19, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 30 slides · Aug 4, 2026
Shareholder Meeting (May 2026)
Shareholder meeting · 22 slides · May 15, 2026
Q1 2026 Earnings Presentation
Earnings · 27 slides · May 5, 2026
FY2025 Earnings Presentation
Earnings · 33 slides · Mar 10, 2026
BioNTech SE on 6ix
- News releases
- 4 in the last 12 months · 4 in all · newest Oct 22, 2026 · oldest 2026
- Decks
- 50 decks · latest Aug 4, 2026
Where BioNTech SE is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BNTX · Home listing · This page | NASDAQ | United States | USD |
| B3:B1NT34 | B3 | Brazil | BRL |
| Xetra:22UA | Xetra | Germany | EUR |
| BMV:BNTXN | BMV | Mexico | MXN |
| BX Swiss:22UA | BX Swiss | Switzerland | CHF |
| LSIN:0A3M | LSIN | United Kingdom | USD |
Log in to ask 6ix AI your own questions about BioNTech SE.